United States

AVROBIO awarded Johnson & Johnson JLabs Incubator Space

Monday, May 16, 2016

AVROBIO, a clinical-stage biotechnology company developing transformative, life-changing gene therapies targeting rare diseases and cancer, has been awarded lab space at Johnson & Johnson’s (J&J) newest JLABS facility in Toronto, Ontario. AVROBIO, headquartered in Cambridge, Massachusetts, with researchers in Toronto, will join other early stage companies in the 40,000 square foot facility opening this spring.

[Read More]

PSI opens office in Research Triangle Park

Wednesday, May 11, 2016

PSI, a global full-service CRO, is opening a new office in Durham, North Carolina, in the region known as Research Triangle Park (RTP). The new office is in addition to the PSI operational offices in King of Prussia, Pennsylvania, and San Francisco, California.

[Read More]

FDA grants Priority Review for Lilly’s Olaratumab

Monday, May 9, 2016

The FDA has granted Priority Review for the biologics license application (BLA) for Eli Lilly’s olaratumab, a PDGFRα antagonist, in combination with doxorubicin, for the potential treatment of people with advanced soft tissue sarcoma (STS) not amenable to curative treatment with radiotherapy or surgery.

[Read More]